This site is intended for healthcare professionals
News

Semorinemab,anti-Tau antibody, in early Alzheimer’s disease fails in Phase II trial.- AC Immune + Genentech Roche.

Read time: 1 mins
Last updated:24th Sep 2020
Published:24th Sep 2020
Condition: Alzheimers
Type: drug
Register free for full access to medthority.com